Luminex Corp (LMNX1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Nachum Shamir
Employees:
1,141
12212 TECHNOLOGY BLVD, 512-219-8020, AUSTIN, TX 78727
5122494741

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Data derived from most recent annual or quarterly report
Market Cap 1.75 Billion Shares Outstanding47.314 Million Avg 30-day Volume 510.937 Thousand
P/E Ratio64.1676 Dividend Yield1.1945 EPS0.51
Price to Revenue3.3928 Debt to Equity0.5194 EBITDA51.81 Million
Price to Book Value3.0425 Operating Margin12.398000000000001 Enterprise Value1.467 Billion
Current Ratio8.37 EPS Growth4.333 Quick Ratio5.917
1 Yr BETA 0.1738 52-week High/Low 0.0 / Profit Margin5.3919
Operating Cash Flow Growth165.2232 Altman Z-Score4.1676 Free Cash Flow to Firm -17.701 Million
View SEC Filings from LMNX1 instead.

View recent insider trading info

Funds Holding LMNX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LMNX1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KEVER JIM D

  • Director
0 2021-07-14 1

ERICKSON THOMAS W

  • Director
0 2021-07-14 1

MCNAMARA KEVIN M

  • Director
0 2021-07-14 1

CURRIE HARRISS T SVP, FINANCE & CFO

  • Officer
0 2021-07-14 1

OGUNRO EDWARD A

  • Director
0 2021-07-14 1

LEWIS DIJUANA K

  • Director
0 2021-07-14 1

SAMET KENNETH A

  • Director
0 2021-07-14 1

REW RICHARD W. II SVP, GEN COUNSEL & CORP SECY

  • Officer
0 2021-07-14 1

SHAMIR NACHUM PRESIDENT & CEO

  • Officer
  • Director
0 2021-07-14 1

FAIRCHILD NANCY SVP, HUMAN RESOURCES

  • Officer
0 2021-07-14 1

MYERS RANDALL SVP, GLOBAL MFG AND QUALITY

  • Officer
0 2021-07-14 1

ECK STEPHEN L.

  • Director
0 2021-07-14 1

BENNETT TODD C. SVP, GLOBAL SALES & CUST OPS

  • Officer
0 2021-07-14 1

SHAPIRO ERIC SR VP, GLOBAL MARKETING

  • Officer
0 2021-07-14 1

COLLINS CHARLES J. SR VP, R&D - US

  • Officer
0 2021-07-14 1

LOEWENBAUM G WALTER II

  • Director
No longer subject to file 2020-08-04 0

CRESCI ROBERT J

  • Director
220,157 2018-05-17 0

LAZARUS TADD S. SVP, CHIEF MEDICAL OFFICER

  • Officer
10,495 2017-03-10 0

JOHNSTON JAY B

  • Director
146,696 2016-05-19 0

BRADLEY RUSSELL W SVP, CORP DEV & CMO

  • Officer
100,667 2016-03-22 0

GOAD FRED C JR

  • Director
300,767 2015-05-14 0

BRIDGE-COOK JEREMY K SVP, RESEARCH AND DEVELOPMENT

  • Officer
74,273 2015-03-12 0

BALTHROP PATRICK J PRESIDENT & CEO

  • Officer
  • Director
646,873 2014-05-14 0

REITER DAVID S SVP & GENERAL COUNSEL

  • Officer
60,400 2014-05-01 0

PINTEK MICHAEL F SVP, OPERATIONS

  • Officer
62,236 2014-03-13 0

DEHNE TIMOTHY R VP, SYSTEMS R&D

  • Officer
20,441 2013-08-16 0

VAILLANT GERARD

  • Director
61,842 2012-05-23 0

GOSCH GREGORY J VP, BIOSCIENCE GROUP

  • Officer
55,380 2010-05-13 0

THOMPSON J STARK PHD

  • Director
18,289 2008-11-26 0

CARRANO JOHN C VP, RESEARCH & DEVELOPMENT

  • Officer
43,913 2008-11-17 0

BRYANT DOUGLAS C EVP, CHIEF OPERATING OFFICER

  • Officer
68,428 2008-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LUMINEX CORP LMNX 2021-07-14 22:15:03 UTC -0.1729 0.2529 2400000
LUMINEX CORP LMNX 2021-07-14 21:45:03 UTC -0.1729 0.2529 2400000
LUMINEX CORP LMNX 2021-07-14 21:15:03 UTC -0.1729 0.2529 2400000
LUMINEX CORP LMNX 2021-07-14 20:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 20:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 19:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 19:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 18:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 18:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 17:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 17:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 16:45:04 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 16:15:03 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 15:45:02 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 15:15:03 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 14:45:03 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 14:15:03 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 13:45:03 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 13:15:02 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 12:45:02 UTC -0.2023 0.2823 2400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Defensive Long Fund LMNX1 -105.0 shares, $-2890.65 2020-03-31 N-PORT

Elevate your investments